在NIR反应的PLA/MXene支架上装有药物的微球:可控释放和骨组织再生
Yiqiao Zhao1, Hao Chen2, Jiahao Fu2
1Nanjing University of Science and Technology, 200, Xiaolingwei Street, Nanjing 210094, China.
ACS applied bio materials
|January 2, 2025
概括
这项研究引入了一种新的骨瘤治疗支架,结合了多乳酸,MXene和含药微球. 脚手架有效地抑制瘤复发,并通过近红外光激活促进骨修复.
科学领域:
- 生物材料科学 生物材料科学
- 整形瘤学 整形瘤学
- 纳米技术 纳米技术
背景情况:
- 骨瘤切除通常会导致残留的瘤细胞出现大缺陷,这在平衡骨修复和抗瘤治疗方面构成了挑战.
- 目前的治疗方法很难同时解决骨再生问题,并有效地预防瘤复发.
研究的目的:
- 开发一个多功能,近红外 (NIR) 响应的支架,用于瘤切除后骨缺陷的综合治疗.
- 通过光热疗法 (PT) 实现双向调制,以增强抗瘤效果和骨修复.
主要方法:
- 使用聚乳酸和MXene制造复合脚手架,装载PLGA/DOX微球.
- 对NIR响应光热特性和受控药物释放动力学的评估.
- 在体内评估脚手架在抑制瘤复发和促进骨质生成方面的有效性.
主要成果:
- 1%MXene含量的脚手架显示出高效的光热转换,在NIR照明下在2分钟内达到50°C.
- 与体温相比,NIR照射增加了10%的药物释放,增强了药物输送.
- 在体内研究证实了脚手架在NIR照射下限制瘤复发,减少肺转移,促进骨质分化的能力.
结论:
- 开发的NIR响应性支架通过控制药物释放并通过PT增强抗瘤作用,为骨瘤综合治疗提供了一个有前途的解决方案.
- 这种方法同时促进了骨的形成,解决了治疗瘤手术后骨缺陷的关键需求.
相关概念视频
Modified-Release Drug Delivery Systems: Stimuli-Activated
177
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
177
Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160


